A new study found that disease flares may be uncommon after receiving the COVID-19 vaccine, particularly for patients who haven’t experienced a flare in six months.
Continue reading
“I’ve heard friends say passing off a hangover gets harder the older they get, but they haven’t had to pass off a hangover while living with a chronic illness,” says Eileen Davidson, who has rheumatoid arthritis and osteoarthritis.
Continue reading
The European Alliance of Associations for Rheumatology (EULAR) task force recently developed recommendations to help improve self-management strategies of patients with inflammatory arthritis. The recommendations involve taking an active role in learning about your condition and engaging in shared decision-making.
Continue reading
In our Arthritis Awareness Month campaign that sought to raise awareness of the challenges of living with invisible illnesses, community members shared what others do to make them — and their illness — more visible. Many said they feel less invisible when they are listened to and included.
Continue reading
Many members of the CreakyJoints and Global Healthy Living Foundation community immediately sought to receive a third vaccine dose after they became available in the U.S. to people who are immunocompromised. Here’s a round-up of what it’s been like so far.
Continue reading
According to a new study, cannabis use among people with rheumatic disease has tripled from 6 percent in 2014 to 18 percent in 2019.
Continue reading
In the Global Healthy Living Foundation’s latest COVID-19 Patient Support Program poll, 72 percent of immunocompromised patients said they are moderately to very worried about the Delta variant of COVID-19 — and it’s affecting their everyday behaviors and habits.
Continue reading
The treatment doesn’t replace a vaccine, but it’s a helpful tool in protecting yourself against infection if you’re high-risk for severe COVID-19 outcomes.
Continue reading
Researchers looked at the characteristics and outcomes of COVID-19 breakthrough infections among fully vaccinated people with rheumatic disease, such as rheumatoid arthritis and lupus. They found that, though cases were limited, the outcomes were more severe among this group than in the general population.
Continue reading
